Inspirna to Present Clinical Data from Phase 1b/2 Study of O

Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid (RGX-202) in Advanced Colorectal Cancer at ESMO Congress 2023

Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid (RGX-202) in Advanced Colorectal Cancer at ESMO Congress 2023

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Madrid , Spain , New York , United States , Rockefeller University , Alexandria , Al Iskandariyah , Egypt , Andrew Hendifar , Product Service , Bristol Myers Squibb , Novo Holdings , European Society For Medical Oncology , Wuxi Pharmatech Healthcare Fund , Alexandria Venture Investments , Lepu Holdings , Inspirna Inc , Sinai Medical Center , Silicon Valley Bank , Partnership Fund For New York City , Present Clinical Data , Advanced Colorectal Cancer , European Society , Medical Oncology , Assistant Professor , Cedars Sinai Medical Center , Study Principal Investigator , Poster Display Date , Bristol Myers , Sofinnova Partners , Sands Capital , Vivo Capital , Lepu Holdings Limited , Sixty Degree Capital , Oceanpine Capital , Exor Seeds , Partnership Fund ,